Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study.

Authors:
Cai H; Chen S; Wu Z; Wang F; Tang S and 2 more

Journal:
J Hepatocell Carcinoma

Publication Year: 2024

DOI:
10.2147/JHC.S439001

PMCID:
PMC10906278

PMID:
38435682

Journal Information

Full Title: J Hepatocell Carcinoma

Abbreviation: J Hepatocell Carcinoma

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure All authors declare that they have no competing interests in this work."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025